DIA Pharmacovigilance and Risk Management Strategies

Date: 
Monday, January 23, 2017 to Wednesday, January 25, 2017
Location: 
Washington, D.C.
Body: 

Visit our team at booth #4

 

Panel Discussion: The FDA IND Rule on Safety Reporting

Annette Stemhagen, DrPH, FISPE, Senior Vice President, Safety, Epidemiology, Registries & Risk Management